European Companies Search Engine
EU funding (€226,413): The therapeutic potential of Genipin as a corneal cross-linking agent: Unlocking a new pathway for the treatment of corneal infection and disease. Hor 8 May 2018 EU Research and Innovation programme "Horizon"
Text
This publication is not available.
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Universidad Nacional DE Colombia, Bogota, Colombia.